Carroll Cross is a Respiratory physician affiliated with University of California, Davis. OpenAlex indexes 238 publications with 15,328 citations (h-index 62). By OpenAlex citation count, this profile ranks in the top 10% of Pulmonary Disease profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4150 V St
Ste 3400, Division Of Pulmonary And Critical Care Med
Sacramento, CA 958171460
Telephone
916-734-3564Registry record last updated 4 Jan 2012.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Chiesi USA, Inc.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2019)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Blood & clotting
100%Human alpha-1 Proteinase Inhibitor100%Zemaira100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
6 NIH research awards on record, funded 1985–2011 per NIH RePORTER. The latest:
- Therapeutic Targeting of Myeloperoxidase in Acute Inflammation
University of California at Davis
FY2011$229,500R21HL092506 - Therapeutic Targeting of Myeloperoxidase in Acute Inflammation
University of California at Davis
FY2009$186,738R21HL092506
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The Diagnosis and Management of Alpha-1 Antitrypsin Deficiency in the Adult
Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation
2016 - Metabolomic profiling of regulatory lipid mediators in sputum from adult cystic fibrosis patients
Free Radical Biology and Medicine
2012 - Evidence of Health Impacts of Sulfate-and Nitrate-Containing Particles in Ambient Air
Inhalation Toxicology
2007 - Does γ-Tocopherol Play a Role in the Primary Prevention of Heart Disease and Cancer? A Review
Journal of the American College of Nutrition
2006
Similar KOLs
Other experts from the same institution or the same specialty.
Michael Rogawski, MD
University of California, Davis
Christopher Bowlus, MD
University of California, Davis
Emanual Maverakis, MD
University of California, Davis
Soe Thein, MD
University of California, Davis
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Marshall University
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”